IQGAP3 and breast cancer: To confirm whether IQGAP3 is overexpressed in radioresistant breast cancer patients, we also examined IQGAP3 expression in 159 post-RT patients (radioresistant group n = 19; radiosensitive group n = 140) using IHC.